Article
Advances in technologies for screening and diagnosis of hemoglobinopathies.
Biomarkers in medicine - 1 Jan 2014
Traeger-Synodinos Jan, Harteveld Cornelis L
Abstract excerpt
Hemoglobinopathies constitute the most common monogenic disorders worldwide, caused by mutations in the globin genes that synthesize the globin chains of hemoglobin. Synthesis may be reduced (thalassemia) or underlie abnormal hemoglobins. Mutation interactions produce a wide range of disorders. For neonatal and antenatal screening, identification of affected newborns or carriers is achieved by hematological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
